Can hydroxyzine cause a false‑positive result on a plasma free fractionated metanephrines test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydroxyzine Does Not Cause False-Positive Plasma Free Metanephrines

Hydroxyzine is not known to interfere with plasma free fractionated metanephrines testing and is not listed among medications that cause false-positive results for pheochromocytoma/paraganglioma screening.

Evidence-Based Analysis

What Actually Causes False-Positives

The Endocrine Society guidelines 1 specifically identify medications that interfere with metanephrine testing, including:

  • Tricyclic antidepressants (which cause significant interference)
  • Drugs that directly interfere with measurement methods (acetaminophen, mesalamine, sulfasalazine)
  • Medications affecting catecholamine disposition

Recent high-quality research 2 confirms that norepinephrine reuptake blockers (tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors) are the primary culprits, increasing:

  • Plasma normetanephrine by 40% (false-positive rate rising from 4.8% to 23.0%)
  • Methoxytyramine by 127% (false-positive rate rising from 0.9% to 28.6%)

Additional research 3 identifies that α1-blockers, antidepressants, and antipsychotics can affect urinary fractionated metanephrines, but notably hydroxyzine is not mentioned.

Hydroxyzine's Known Interferences

The FDA drug label 4 for hydroxyzine does not mention any interference with catecholamine or metanephrine testing. The documented interferences for hydroxyzine are limited to:

  • Tricyclic antidepressant immunoassays (FPIA method) - confirmed by research 5
  • CNS depressant potentiation
  • QT prolongation risk

Research 5 specifically demonstrates that hydroxyzine causes false-positive TCA immunoassays but explicitly states it does not interfere with other assays tested.

Clinical Implications

When to Suspect True Interference

If you encounter an elevated plasma metanephrine result in a patient on hydroxyzine:

  • Do not attribute it to hydroxyzine - look for other causes
  • Review for actual interfering medications (tricyclics, SNRIs, α1-blockers)
  • Ensure proper collection technique (supine position for 30 minutes) 1
  • Consider physiological stress, laboratory error, or actual tumor

Common Pitfalls to Avoid

  • Do not discontinue hydroxyzine based on elevated metanephrines - it's not the cause
  • Recognize that hydroxyzine's cross-reactivity is limited to TCA immunoassays, not catecholamine metabolite testing
  • Remember that false-positive drug screens (amphetamines, TCAs) are different from false-positive biochemical tumor markers

The evidence clearly distinguishes between drugs causing false-positive drug screens versus those affecting metanephrine measurements - hydroxyzine falls only in the former category 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.